The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial

BACKGROUND: Approximately 30% of HIV-1-infected patients receiving antiretroviral therapy who achieve virologic control have unsatisfactory immune reconstitution, with CD4+ T-cell counts persistently below 350 cells/μL. These patients are at elevated risk for clinical progression to AIDS and non-AID...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebouché, Bertrand, Jenabian, Mohammad-Ali, Singer, Joel, Graziani, Gina M, Engler, Kim, Trottier, Benoit, Thomas, Réjean, Brouillette, Marie-Josée, Routy, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283109/
https://www.ncbi.nlm.nih.gov/pubmed/25293882
http://dx.doi.org/10.1186/1745-6215-15-390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283109/
https://www.ncbi.nlm.nih.gov/pubmed/25293882
http://dx.doi.org/10.1186/1745-6215-15-390

Ejemplares similares